Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancer

about

Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancer

Item

http://www.wikidata.org/entity/Q37717749

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Consideration of EphA2 in rela ...... in uterine endometrial cancer

@en

Consideration of EphA2 in rela ...... in uterine endometrial cancer.

@nl

type

Item

label

Consideration of EphA2 in rela ...... in uterine endometrial cancer

@en

Consideration of EphA2 in rela ...... in uterine endometrial cancer.

@nl

prefLabel

Consideration of EphA2 in rela ...... in uterine endometrial cancer

@en

Consideration of EphA2 in rela ...... in uterine endometrial cancer.

@nl

P1476

Consideration of EphA2 in rela ...... in uterine endometrial cancer

@en

P2093

Jee Young Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

Correlation between the overexpression of epidermal growth factor receptor and mesenchymal makers in endometrial carcinoma.

EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.

EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.

Cell adhesion and EGFR activation regulate EphA2 expression in cancer.

Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.

Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma.

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.

P304

155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2014.25.2.155

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261841348

http://www.w3.org/2001/XMLSchema#string

P698

24761220

http://www.w3.org/2001/XMLSchema#string

P932

3996266

http://www.w3.org/2001/XMLSchema#string